TnT predicts reperfusion on day-one
This article was originally published in Clinica
TnT accurately predicts reperfusion after thrombolysis on day one. Researchers from the University Hospital in Maastricht said the test was highly sensitive and specific. The group, led by Dr Britta Goldmann, took TnT readings from 131 patients enrolled in the SESAM (alteplase versus saruplase) trial.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.